Literature DB >> 24328016

Gynecologic complication of chronic graft-versus-host disease: Vaginal obstruction.

Junsik Park1, Tae-Hee Kim, Hae-Hyeog Lee, Soo-Ho Chung, Daegeun Lee.   

Abstract

Allogenic peripheral blood stem cell transplantation (Allo-PBSCT) is being used to treat hematological malignancies with increasing frequency. Graft-versus-host disease (GvHD) is a complex complication of PBSCT. A 43-year-old woman came to the gynecology clinic for amenorrhea. She had been diagnosed with acute myeloid leukemia 2 years earlier and treated with induction and consolidation chemotherapy. After developing complete remission, she underwent Allo-PBSCT. When she started chemotherapy, her menstrual cycle completely disappeared. Fourteen months after menopausal hormone replacement therapy, it was discovered that her upper vaginal canal was completely obstructed. The lower vagina had an atrophic appearance. We report a rare case of partial vaginal obstruction as a complication of chronic GvHD and review the literature. We expect that this case report provides an opportunity to remind clinician of the gynecologic complications of GvHD.

Entities:  

Keywords:  Graft vs host disease; Hematocolpos; Peripheral blood stem cell transplantation; Vagina

Year:  2013        PMID: 24328016      PMCID: PMC3784143          DOI: 10.5468/ogs.2013.56.4.277

Source DB:  PubMed          Journal:  Obstet Gynecol Sci        ISSN: 2287-8572


  15 in total

1.  Lichen sclerosus et atrophicus in sclerodermatous chronic graft-versus-host disease.

Authors:  S Córdoba; E Vargas; J Fraga; M Aragüés; J Fernández-Herrera; A García-Díez
Journal:  Int J Dermatol       Date:  1999-09       Impact factor: 2.736

2.  Vaginal stenosis with hematocolpometra, complicating chronic graft versus host disease.

Authors:  Jean-Luc Anguenot; Victoria Ibéchéole; Claudine Helg; Jean-Michel Piacenza; Patrick Dumps; Hervé Bonnefoi
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2002-07-10       Impact factor: 2.435

3.  Treatment of vaginal agglutination associated with chronic graft-versus-host disease.

Authors:  Ellen C Hayes; John A Rock
Journal:  Fertil Steril       Date:  2002-11       Impact factor: 7.329

4.  Gynecologic manifestations of chronic graft-versus-host disease.

Authors:  S L Corson; K Sullivan; F Batzer; C August; R Storb; E D Thomas
Journal:  Obstet Gynecol       Date:  1982-10       Impact factor: 7.661

5.  Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.

Authors:  S Carlens; O Ringdén; M Remberger; B Lönnqvist; H Hägglund; S Klaesson; J Mattsson; B M Svahn; J Winiarski; P Ljungman; J Aschan
Journal:  Bone Marrow Transplant       Date:  1998-10       Impact factor: 5.483

Review 6.  Graft-versus-host disease.

Authors:  James L M Ferrara; John E Levine; Pavan Reddy; Ernst Holler
Journal:  Lancet       Date:  2009-03-11       Impact factor: 79.321

7.  Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

Authors:  Stephanie J Lee; John P Klein; A John Barrett; Olle Ringden; Joseph H Antin; Jean-Yves Cahn; Matthew H Carabasi; Robert Peter Gale; Sergio Giralt; Gregory A Hale; Osman Ilhan; Philip L McCarthy; Gerard Socie; Leo F Verdonck; Daniel J Weisdorf; Mary M Horowitz
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

8.  Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.

Authors:  Daniel Couriel; Paul A Carpenter; Corey Cutler; Javier Bolaños-Meade; Nathaniel S Treister; Juan Gea-Banacloche; Paul Shaughnessy; Sharon Hymes; Stella Kim; Alan S Wayne; Jason W Chien; Joyce Neumann; Sandra Mitchell; Karen Syrjala; Carina K Moravec; Linda Abramovitz; Jerry Liebermann; Ann Berger; Lynn Gerber; Mary Schubert; Alexandra H Filipovich; Daniel Weisdorf; Mark M Schubert; Howard Shulman; Kirk Schultz; Barbara Mittelman; Steven Pavletic; Georgia B Vogelsang; Paul J Martin; Stephanie J Lee; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2006-04       Impact factor: 5.742

9.  Hormone replacement therapy and chronic graft-versus-host disease activity in women treated with bone marrow transplantation for hematologic malignancies.

Authors:  Enrico Balleari; Simona Garre; Maria Teresa Van Lint; Simonetta Spinelli; Sandra Chiodi; Enrico Repetto; Giulio Massa; Andrea Bacigalupo; Riccardo Ghio
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

10.  Female reproductive potential after treatment for Hodgkin's disease.

Authors:  S J Horning; R T Hoppe; H S Kaplan; S A Rosenberg
Journal:  N Engl J Med       Date:  1981-06-04       Impact factor: 91.245

View more
  3 in total

Review 1.  Reproductive issues in patients undergoing Hematopoietic Stem Cell Transplantation: an update.

Authors:  Maurizio Guida; Maria Antonietta Castaldi; Rosa Rosamilio; Valentina Giudice; Francesco Orio; Carmine Selleri
Journal:  J Ovarian Res       Date:  2016-11-01       Impact factor: 4.234

2.  Vulvar and Vaginal Graft versus Host Disease: A Healthcare Clinic Initiative.

Authors:  Naomi Van Dam; Revital Zelker; Ruth Radiano; Ilana Kadmon; Bella Bogorochin; Yevgeni Frank-Kamenetsky
Journal:  Asia Pac J Oncol Nurs       Date:  2017 Apr-Jun

3.  Menopause in women with chronic immunosuppressive treatment - how to help those patients.

Authors:  Anna Cyganek; Bronisława Pietrzak; Mirosław Wielgoś; Barbara Grzechocińska
Journal:  Prz Menopauzalny       Date:  2016-03-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.